[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address 50.16.107.222. Please contact the publisher to request reinstatement.
[Skip to Content Landing]
Views 517
Citations 0
Editorial
July 2016

Linking Genotype to Clinical Phenotype in Multiple SclerosisIn Search of the Holy Grail

Author Affiliations
  • 1Department of Neurology, Yale School of Medicine, New Haven, Connecticut
  • 2Department of Neurology, Washington University in St Louis, St Louis, Missouri
  • 3Department of Immunobiology, Yale School of Medicine, New Haven, Connecticut
JAMA Neurol. 2016;73(7):777-778. doi:10.1001/jamaneurol.2016.1227

The clinical heterogeneity associated with progression to disability remains one of the mysteries surrounding multiple sclerosis (MS) and can be a source of consternation to patients and physicians alike. Patients who appear neurologically comparable at diagnosis often have widely divergent disease courses: some progress rapidly and require assistance to ambulate within a few years; others experience few relapses and remain almost neurologically intact for decades. Many have hypothesized that the phenotypic variability of MS stems from underlying genetic differences between patients.

First Page Preview View Large
First page PDF preview
First page PDF preview
×